BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7558729)

  • 1. In vivo measurement of lipofuscin in Stargardt's disease--Fundus flavimaculatus.
    Delori FC; Staurenghi G; Arend O; Dorey CK; Goger DG; Weiter JJ
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2327-31. PubMed ID: 7558729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics.
    Delori FC; Dorey CK; Staurenghi G; Arend O; Goger DG; Weiter JJ
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):718-29. PubMed ID: 7890502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of visual acuity loss in patients with different stages of Stargardt's disease.
    Kim LS; Fishman GA
    Ophthalmology; 2006 Oct; 113(10):1748-51. PubMed ID: 16872677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin treatment inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.
    Radu RA; Mata NL; Nusinowitz S; Liu X; Travis GH
    Novartis Found Symp; 2004; 255():51-63; discussion 63-7, 177-8. PubMed ID: 14750596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A special form of Stargardt's disease/fundus flavimaculatus].
    Suzuki R; Hirose T
    Nippon Ganka Gakkai Zasshi; 1996 Jul; 100(7):562-7. PubMed ID: 8741342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo fundus fluorescence measurements in patients with age related macular degeneration].
    Arend O; Weiter JJ; Goger DG; Delori FC
    Ophthalmologe; 1995 Oct; 92(5):647-53. PubMed ID: 8750989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope.
    von Rückmann A; Fitzke FW; Bird AC
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):478-86. PubMed ID: 9040481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of Stargardt's disease and fundus flavimaculatus.
    Armstrong JD; Meyer D; Xu S; Elfervig JL
    Ophthalmology; 1998 Mar; 105(3):448-57; discussion 457-8. PubMed ID: 9499775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of central visual function in Stargardt's disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography.
    Ergun E; Hermann B; Wirtitsch M; Unterhuber A; Ko TH; Sattmann H; Scholda C; Fujimoto JG; Stur M; Drexler W
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):310-6. PubMed ID: 15623790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stargardt's disease and fundus flavimaculatus].
    François P; Turut P; Puech B; Hache JC
    Arch Ophtalmol Rev Gen Ophtalmol; 1975 Nov; 35(11):817-46. PubMed ID: 131535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipofuscinosis and subretinal fibrosis in Stargardt's disease.
    De Laey JJ; Verougstraete C
    Retina; 1995; 15(5):399-406. PubMed ID: 8594632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.
    Radu RA; Mata NL; Nusinowitz S; Liu X; Sieving PA; Travis GH
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4742-7. PubMed ID: 12671074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indocyanine green angiography in Stargardt's flavimaculatus.
    Wroblewski JJ; Gitter KA; Cohen G; Schomaker K
    Am J Ophthalmol; 1995 Aug; 120(2):208-18. PubMed ID: 7639305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The electroretinogram in Stargardt's disease and fundus flavimaculatus.
    Lachapelle P; Little JM; Roy MS
    Doc Ophthalmol; 1989 Dec; 73(4):395-404. PubMed ID: 2637122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal function in Stargardt's disease and fundus flavimaculatus.
    Moloney JB; Mooney DJ; O'Connor MA
    Am J Ophthalmol; 1983 Jul; 96(1):57-65. PubMed ID: 6869480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipofuscin and the principles of fundus autofluorescence: a review.
    Nandakumar N; Buzney S; Weiter JJ
    Semin Ophthalmol; 2012; 27(5-6):197-201. PubMed ID: 23163276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant inheritance of Stargardt's disease.
    Bither PP; Berns LA
    J Am Optom Assoc; 1988 Feb; 59(2):112-7. PubMed ID: 3361050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of fluorescein angiography in the diagnosis of Stargardt's mascular degeneration (author's transl)].
    Hammerstein W; Leide E
    Klin Monbl Augenheilkd; 1981 Jan; 178(1):20-3. PubMed ID: 7230673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological findings in Stargardt's-fundus flavimaculatus disease.
    Stavrou P; Good PA; Misson GP; Kritzinger EE
    Eye (Lond); 1998; 12 ( Pt 6)():953-8. PubMed ID: 10325994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.
    Holz FG; Bellman C; Staudt S; Schütt F; Völcker HE
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1051-6. PubMed ID: 11274085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.